Clinical Trial Update: A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This is a Phase 1 trial investigating CT-388 in otherwise healthy overweight and obese adults and patients with type 2 diabetes mellitus; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• CT-388

Snippet

Sponsor: Carmot Therapeutics, Inc. | Conditions: Diabetes | Phase 1 | Status: COMPLETED